Document Detail


Proteasome activation during cardiac hypertrophy by the chaperone H11 Kinase/Hsp22.
MedLine Citation:
PMID:  18006445     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: The regulation of protein degradation by the proteasome during cardiac hypertrophy remains largely unknown. Also, the proteasome translocates to the nuclear periphery in response to cellular stress in yeast, which remains unexplored in mammals. The purpose of this study was to determine the quantitative and qualitative adaptation of the proteasome during stable cardiac hypertrophy.
METHODS AND RESULTS: We measured proteasome activity, expression and sub-cellular distribution in a model of chronic cardiac hypertrophy induced by the stress-response chaperone H11 Kinase/Hsp22 (Hsp22). Over-expression of Hsp22 in a transgenic (TG) mouse leads to a 30% increase in myocyte cross-sectional area compared to wild-type (WT) mice (P < 0.01). Characterization of the proteasome in hearts from TG mice vs. WT revealed an increased expression of both 19S and 20S subunits (P < 0.05), a doubling in 20S catalytic activity (P < 0.01), a redistribution of both subunits from the cytosol to the nuclear periphery, and a four-fold increase in nuclear-associated 20S catalytic activity (P < 0.001). The perinuclear proteasome co-localized and interacted with Hsp22. Inhibition of proteasome activity by epoxomicin reduced hypertrophy in TG by 50% (P < 0.05). Adeno-mediated over-expression of Hsp22 in isolated cardiac myocytes increased both cell growth and proteasome activity, and both were prevented upon inhibition of the proteasome. Similarly, stimulation of cardiac cell growth by pro-hypertrophic stimuli increased Hsp22 expression and proteasome activity, and proteasome inhibition in that setting prevented hypertrophy. Proteasome inhibitors also prevented the increase in rate of protein synthesis observed after over-expression of Hsp22 or upon addition of pro-hypertrophic stimuli.
CONCLUSIONS: Hsp22-mediated cardiac hypertrophy promotes an increased expression and activity, and a subcellular redistribution of the proteasome. Inhibition of the proteasome reverses cardiac hypertrophy upon Hsp22 over-expression or upon stimulation by pro-hypertrophic hormones, and also blocks the stimulation of protein synthesis in these conditions.
Authors:
Nadia Hedhli; Li Wang; Qian Wang; Eman Rashed; Yimin Tian; Xiangzhen Sui; Kiran Madura; Christophe Depre
Related Documents :
18006445 - Proteasome activation during cardiac hypertrophy by the chaperone h11 kinase/hsp22.
12874135 - Selective degradation of excess ldb1 by rnf12/rlim confers proper ldb1 expression level...
17604855 - Biting the hand that feeds: rpn4-dependent feedback regulation of proteasome function.
20980825 - Redundancy and variation in the ubiquitin-mediated proteolytic targeting of a transcrip...
14618255 - Dynamic interactions of nuclear lamina proteins with chromatin and transcriptional mach...
16837225 - Bezafibrate induces faldh in human fibroblasts; implications for sjögren-larsson syndro...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2007-10-30
Journal Detail:
Title:  Cardiovascular research     Volume:  77     ISSN:  0008-6363     ISO Abbreviation:  Cardiovasc. Res.     Publication Date:  2008 Feb 
Date Detail:
Created Date:  2008-01-30     Completed Date:  2008-08-26     Revised Date:  2012-05-28    
Medline Journal Info:
Nlm Unique ID:  0077427     Medline TA:  Cardiovasc Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  497-505     Citation Subset:  IM    
Affiliation:
New Jersey Medical School, Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, 185 South Orange Avenue, MSB G-609, Newark, NJ 07103, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cardiomegaly / enzymology,  etiology*,  prevention & control
Cell Proliferation
Enzyme Activation
HSP20 Heat-Shock Proteins / physiology*
Mice
Mice, Transgenic
Muscle Proteins / physiology*
Proteasome Endopeptidase Complex / antagonists & inhibitors,  physiology*
Grant Support
ID/Acronym/Agency:
HL072863/HL/NHLBI NIH HHS; P01 HL069020/HL/NHLBI NIH HHS; R01 HL072863/HL/NHLBI NIH HHS; R01 HL093415/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/HSP20 Heat-Shock Proteins; 0/Hspb8 protein, mouse; 0/Muscle Proteins; EC 3.4.25.1/Proteasome Endopeptidase Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improve...
Next Document:  S-nitroso human serum albumin reduces ischaemia/reperfusion injury in the pig heart after unprotecte...